Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

View of the banner deployed by MSF in front of the World Trade Organization (WTO) in Geneva calling on certain governments to stop blocking the landmark waiver proposal on intellectual property (IP) during the pandemic. Photograph by Pierre-Yves Bernard
Press release
Press release |
10 June 2021
COVID-19

MSF response to the European Parliament’s resolution supporting the ‘TRIPS waiver’

3 min
MSF COVID-19 emergency projects in Rondônia, Brazil. Photograph by Diego Baravelli
Press release
Press release |
07 June 2021
COVID-19

EU, UK, Switzerland, Norway must stop blocking negotiations on landmark pandemic monopoly waiver

6 min
Bonifácia de Oliveira, 109-years-old, was a COVID-19 patient that left a mark on everyone at Tefé Regional Hospital due to her determination and physical and emotional stability. She worked all her life in agriculture and became literate at the age of 100. Photograph by Mariana Abdalla
Press release
Press release |
04 June 2021
COVID-19

MSF: US global COVID-19 vaccine distribution plan is not enough

3 min
MSF’s Health Educator distributing soaps to a street- hawker in M-East Ward, Mumbai. Photograph by Premananda Hessenkamp
Press release
Press release |
21 May 2021
COVID-19

MSF responds to revised proposal on TRIPS waiver submitted to WTO by sponsoring governments

3 min
""
Press release
Press release |
17 May 2021
COVID-19

MSF: US must commit to sharing more surplus COVID-19 vaccine doses

3 min
David was admitted at the HBCTRH after he falling sick. He had cryptococcal meningitis and Karposi Sarcoma – a kind of cancer common among HIV-positive patients who are failing treatment. The KS had affected his left leg as well and he has to walk using supports. Photograph by Paul Odongo
Press release
Press release |
13 May 2021
HIV/AIDS

Ending deaths from cryptococcal meningitis in a decade is possible – but more action needed before UN meeting on HIV/AIDS

4 min
Moussa, 6 years old, was diagnosed with diabetes type I, two years ago. Photograph by Jinane Saad
Press release
Press release |
12 May 2021
Diabetes

100 years after the discovery of insulin, governments and health leaders have a crucial opportunity to support a new global resolution on diabetes and insulin access

5 min
"" Photograph by Pierre-Yves Bernard
Press release
Press release |
06 May 2021
COVID-19

COVID-19 test maker Cepheid’s price announcement falls far short of what countries need

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury